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ABSTRACT An extensive conformational study of the analgesic dipeptide kyotorphin (L-Tyr-L-Arg) at different pH values
was performed using a constant-pH molecular dynamics method. This dipeptide showed a remarkable pH-dependent
conformational variety. The protonation of the N-terminal amine was identiﬁed as a key element in the transition between the
more extended and the more packed conformational states, as monitored by the dihedral angle deﬁned by the atoms 1Cb-1Ca-
2Ca-2Cb. Theprincipal-component analysis of kyotorphin identiﬁed twomajor conformational populations (theextended transand
the packed cis) together with conformations that occur exclusively at extreme pH values. Other, less stable conformations were
also identiﬁed, which help us to understand the transitions between the predominant populations. The ﬁtting of kyotorphin’s
conformational space to the structure of morphine resulted in a set of conformers that were able to fulﬁll most of the constraints for
the m-receptor. These results suggest that there may be strong similarities between the kyotorphin receptor and the structural
family of opioid receptors.
INTRODUCTION
The structure, function, and dynamics of most biomolecules
in solution are very dependent on pH (1). pH effects occur via
electrostatic interactions, one of the strongest forces at the
molecular level, and can have a direct inﬂuence on molecular
structure. However, a small peptide does not exhibit a pre-
ferred structure in aqueous solution, but rather an ensemble of
interconverting conformations (2). In this case, pH has a more
subtle effect by changing the distribution of the conformer
populations (3).
Until recently, computational studies dealt with pH
using mostly two simpliﬁed approaches. The ﬁrst consists
of setting the solute (e.g., protein) protonable groups to the
states they would have in a solution at the intended pH and
then performing molecular mechanics/dynamics (MM/MD)
simulations. This means that any desolvation and site-site
interaction effects caused by the solute environment upon
protonation are entirely neglected. The second way consists
of using a rigid solute structure and simpliﬁed electrostatic-
oriented models, such as Poisson-Boltzmann (PB) (4–12),
generalized Born (13–15), or protein dipoles and Langevin
dipoles (16,17). (Several other approaches are discussed in
the literature as well (18–24).) The protonation free energies
thus obtained can then be used for sampling protonation
states by Monte Carlo (MC) (7,25–27) or other approximate
methods (7,16,28–31), making possible the calculation of
pKa values. This approach explicitly considers the effect of
desolvation and site-site interactions, but the use of a single
solute conformation makes it impossible to account for
structural reorganization and protonation-conformation
coupling in general (32–35). These problems can be atten-
uated by the use of linear response approximations that
combine MD with simpliﬁed approaches (16,17,32,36).
Another, more general route is to use recently developed
methods for constant-pH MD (37–50), some of which ex-
plore the complementarity between standard MD and sim-
pliﬁed methods (see Machuqueiro and Baptista (50) for a
more detailed comparison). One of these constant-pH MD
methods, called stochastic titration (39), assumes that the
dynamics of a solute with a ﬁxed protonation state can be
obtained from MM/MD, as usual, and that its electrostatics
at ﬁxed conformation can be captured by a PB model (fol-
lowed by MC sampling of protonation states). Stochastic
titration could successfully predict pKas for succinic acid
(a DpKa of 1.75 for an experimental value of 1.45) (39) and
decalysine (pKa of 10.2 for both simulation and experiment)
(50), showing that the method can properly model the cou-
pling between protonation and conformation in small and
relatively large molecules.
Kyotorphin (KTP) was ﬁrst isolated from bovine brain
by Takagi and co-workers (51,52). The name was assigned
to reﬂect an endorphin-like substance and the fact that it
was discovered in Kyoto, Japan. This endogenous dipeptide
(L-Tyr-L-Arg) belongs to the neuropeptide family (53–58)
due to its opiate-like activity. KTP is distributed unevenly
in regions of rat brain (52) and may be formed both by pro-
cessing precursor proteins and by the biosynthesis from
Tyr and Arg (57). The Tyr-Arg motif exists widely through-
out the brain, not only as KTP, but also as the N-terminal
part of several endogenous analgesic peptides (59,60). Also,
this peptide is very rapidly degraded by aminopeptidases
(61). Many of these properties are typical of neurotransmit-
ters and it is not surprising that KTP has also nonopioid
Submitted June 29, 2006, and accepted for publication November 15, 2006.
Address reprint requests to Anto´nio M. Baptista, Instituto de Tecnologia
Quı´mica e Biolo´gica, Av. da Repu´blica, EAN, Apartado 127, 2781-901
Oeiras, Portugal. Tel.: 351-214469619; Fax: 351-214411277; E-mail:
baptista@itqb.unl.pt.
 2007 by the Biophysical Society
0006-3495/07/03/1836/10 $2.00 doi: 10.1529/biophysj.106.092445
1836 Biophysical Journal Volume 92 March 2007 1836–1845
actions independent of enkephalin release (62). There is
evidence suggesting that KTP does not bind the opiate re-
ceptors (m, d, k) but that instead it exerts a Met-enkephalin-
releasing force (53). These results led to the suggestion
that the dipeptide binds to a speciﬁc receptor (KTP receptor,
KTPr) (56), triggering a cascade of events that leads to strong
analgesia in the brain (57,63). Two mechanisms of action
have been proposed: 1), direct activation of the KTPr, induc-
ingMet-enkephalin release (which can activate the d-receptor),
followed by Gai and phospholipase C activations (64,65);
2), a fast degradation of KTP, resulting in L-Arg, which is a
potent substrate for nitric oxide synthase, with the NO thus
formed inducing the release of Met-enkephalin (66). Despite
the fact that several studies (45,53,54) conﬁrm the existence
of a KTPr, it has not yet been identiﬁed. There is still the
question of whether the KTPr is speciﬁc (45) or the result of
a mixed oligomerization of m- and d-opioid receptors (67).
Recent results suggest that KTP can also release opioid pep-
tides from rat cardiac muscle and have an indirect regulatory
role in b-adrenergic action through cross-talk with opioid
receptors (68).
The molecular interaction between KTP and its receptor
remains unknown. In fact, not much is known besides the
fact that the receptor seems to be functionally coupled to
Gai and that it is strongly antagonized by the dipeptide
L-Leu-L-Arg (64). There are obvious similarities between
KTP and most of the endogenous opioid peptides and even
with morphine. The L-Tyr residue at the ﬁrst position of
the peptide is present in most of the opioid peptides and
is believed to be crucial for receptor recognition (69,70)
due to both p-stacking (71) and hydrogen-bonding with the
alcohol of the phenol group (72). A protonable N-terminal
group is also present in KTP and, when protonated, can form
a salt bridge with an anionic group in the receptor, which is
typical for the morphine/m-receptor interaction (72). Also,
when KTP’s N-terminal group is protonated, the molecule
becomes positively charged, which is an important charac-
teristic present in both dynorphin A and nociceptin/orphanine
FQ. These cationic peptides bind to two receptors that
exhibit a highly acidic second exofacial loop (k-receptor for
dynorphin A and ORL1 receptor for nociceptin/orphanine
FQ) (69,70). On the other hand, there is an important dif-
ference between KTP and the opioid peptides. The intro-
duction of two methyl groups (orto position) in the phenol
ring of the Tyr residue in KTP (H-Dmt-Arg-OH) is det-
rimental to the interaction with the KTPr (62), unlike in the
case of opioid peptides, where replacement of Tyr with Dmt
produces a very signiﬁcant potency enhancement (73). Thus,
the binding site of KTPr interacting with the Tyr residue of
KTP has structural requirements that differ from those of the
binding sites of opioid receptors interacting with the Tyr
residue of opioid peptides (62).
Recently, the structural constraints needed for KTP-
receptor interactions were addressed with a combination
of experimental and theoretical approaches (74). The study
showed that pH has a strong inﬂuence on the conforma-
tional behavior of KTP and an acylated KTP derivative, both
in water and in model systems of membranes. In fact, the
conformational space of KTP is expected to depend strongly
on pH, due to its four titrable sites. Around physiological pH,
the N-terminus protonation state should have a strong effect
on both the conformation and total charge of the molecule.
The aim of this work is threefold. First, this work intends
to study KTP using the stochastic titration method for
constant-pHMD (39,50), which is theoretically more rigorous
than the linear response approximation (LRA) method used
previously (74); analogously to stochastic titration, that LRA
method combines PB/MC and MM/MD, but it introduces
further assumptions (32). The second aim of this work is to
carry out a more extensive conformational analysis of the
system than the one presented by Lopes and co-workers (74).
Third, this work also intends to further test the performance
of the stochastic titration method, which has so far only been
applied to succinic acid (39) and decalysine (50). Overall,
our general objective is to elucidate KTP’s preferred confor-
mations at different pH values and how they correlate with
known structural constraints needed for opioid ligand-receptor
interactions.
COMPUTATIONAL DETAILS AND METHODS
Constant-pH MD method
The constant-pH MD method implemented is the stochastic titration method
previously proposed (39). The current implementation is described in a
recent publication (50), which should be consulted for further details. The
method relies on different sequential blocks (Fig. 1). The ﬁrst block is a PB/
MC calculation. The protonation states resulting from the last MC step are
assigned to the protein. The second block is the solvent-relaxation dynamics,
a short MM/MD simulation of the system with frozen protein, which allows
the solvent to adapt to the new protonation states (the duration of this block
is hereafter designated as trlx). The last block is a full MM/MD simulation of
the unconstrained system (the duration of this block is hereafter designated
as tprt). A variant of the reduced titration method is used (31,50), in which
we run a full PB/MC calculation on the system every 10th step to assign a
ﬁxed state to all the sites whose mean occupancies fall outside a predeﬁned
threshold (0.001). This approach is very useful, because, when simulating pH
values too far away from certain site pKas, these become temporarily excluded
from the calculations, hence strongly decreasing the computational cost.
For the PB and MC calculations we used the programs MEAD (75)
and MCRP (27), respectively. The atomic charges and radii used in the PB
calculations were derived from the GROMOS 43A1 force ﬁeld (76,77). All
PB calculations consisted of ﬁnite-difference linear Poisson-Boltzmann
calculations performed with the program MEAD (version 2.2.0) (75) at a
temperature of 300 K, a molecular surface deﬁned with a solvent probe
radius of 1.4 A˚, and a Stern (ion-exclusion) layer of 2.0 A˚. The dielectric
constants were 2 for KTP and 80 for the solvent. A two-step focusing
procedure (78) was used, with consecutive grid spacings of 1.0 and 0.25 A˚.
The MC runs were performed using 105 MC cycles, one cycle consisting of
sequential state changes over all individual sites and also all pairs of sites
with at least one interaction term above 2.0 pKa units (27). In all cases, the
computed average protonations had errors lower than 0.0001; for each site,
this error is computed as the correlation-corrected standard deviation of
the average, taking as correlation time the value at which the autocorrelation
of the protonations goes below 0.1.
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MM/MD settings
All simulations were performed with the GROMOS 43a1 force ﬁeld (76,77)
for the GROMACS 3.2.1 distribution (79,80) (with some modiﬁcations
(50)) and with the SPC water model (81). Periodic boundary conditions were
used with a rhombic dodecahedral unit cell. A twin-range cutoff was used,
with short- and long-range cutoffs of 8 A˚ and 14 A˚, respectively, and with
neighbor lists updated every ﬁve steps. Long-range electrostatics interac-
tions were treated using the generalized-reaction-ﬁeld method (82). The
ionic strength in the simulations was set as an external parameter using a
modiﬁed version of the GROMACS 3.2.1 distribution (50). All bond lengths
were constrained using the LINCS algorithm, and a time step of 2 fs was
used. Two Berendsen’s temperature couplings to baths at 300 K, and with a
relaxation time of 0.1 ps (83), were used for both the solute and solvent. A
Berendsen’s pressure coupling (83) was used with a relaxation time of 0.5 ps
and a compressibility of 4.5 3 105 bar1.
The dipeptide was built in an extended conformation, placed in the
center of the box and ﬁlled with 1199 water molecules. The system was
minimized ﬁrst with ;40 steps of steepest descent followed by ;700 steps
using the low-memory Broyden-Fletcher-Goldfarb-Shanno algorithm. The
initiation was achieved by harmonically restraining all atoms in a 50-ps MD
simulation, followed by another 50 ps simulation with only the CA atoms
restrained. Note that this initiation was done for two different startup
systems, one with the N-terminus deprotonated and the other with the
N-terminus protonated (Tyr and Arg side chains were protonated and the
C-terminus was deprotonated). The charged N-terminus conformation was
used as the starting structure for the simulations at pH 2–7, whereas
simulations at pH 8–12 started with the neutral N-terminus conformation.
Runs of 100 ns were performed and the ﬁrst 5 ns were discarded to get the
system equilibrated. The relaxation of the solvent (trlx) and the full system
dynamics segment (tprt) were done for 1.0 ps each. If tprt is too short, there will
be an increase of computational cost, and if it is too long, we will have a slower
conformational sampling. In this work, the trlx and tprt values were optimized
to get high conformational sampling and good system stability at the expense
of a high computational cost (we ‘‘waste’’ 50% of our MM/MD time).
The main simulations were performed at ionic strength of 0.1 M. Two
extra sets of simulations of 30 ns were performed at ionic strengths 0.0 and
1.0 M and at pH values 3, 5, 6, 7, 8, 9, and 11.
General analysis
All structural analyses were done using GROMACS (79,80) or in-house
tools. Errors were computed using standard methods (84).
Principal-component analysis
Principal-component analysis (PCA) is a method that can be used to simplify
a dataset (85). It is a linear transformation that changes a set of (possibly)
correlated variables into a set of uncorrelated variables called principal
components (PCs). The ﬁrst PC (i.e., the PC with the largest eigenvalue)
accounts for as much of the variability in the data as possible, and each
succeeding PC (in order of decreasing eigenvalues) accounts for as much
of the remaining variability as possible, while being uncorrelated with the
previous ones. The strongest correlations in the dataset tend to be captured
by the ﬁrst PCs. PCA can be used for reducing dimensionality by retaining
only a few of the ﬁrst PCs, hopefully without much loss of information. PCA
is algebraically equivalent to the diagonalization of the covariance matrix:
each PC is the variable associated with an eigenvector, and its variance is
given by the corresponding eigenvalue.
In our analysis, we ﬁtted separately all our trajectories at different pH
values to a ﬁxed KTP structure; changing this structure had no major effect
on the results (data not shown). The atoms subsequently used to calculate the
covariance matrix were CA, CB, CG, and C from Tyr, and N, CA, CB, CG,
and NE from Arg. The trajectories were projected on the ﬁrst three principal
components, which account for ;75% of the information available. The set
of all points (conformations) thus projected was used to obtain a kernel
estimate of the corresponding probability density (86), which was computed
on a grid of (0.1 A˚)3 bins, using a Gaussian kernel and a bandwidth of 0.2 A˚.
This probability density is the projection of the original isothermal-isobaric
distribution onto the subspace spanned by the ﬁrst three PCs, and is expected
to retain the major features of the original distribution. The most populated
peaks of the density (usually the higher ones) were then selected using an
energy cutoff of 2RT, where the energy was computed according to
EðxÞ ¼ RT lnPðxÞ
Pmax
;
where x is the coordinate in the 3D space of the ﬁrst PCs and P(x) is the
probability density at point x. A representative conformation was chosen for
each peak, namely the one closest to the peak top.
RESULTS AND DISCUSSION
Titration with constant-pH MD
The titration of KTP (Figs. 2 and 3) was computed by
averaging at each pH value the occupancy states of all four
titrable sites over 95 ns for the simulations at ionic strength
0.1 M, and over 25 ns for the simulations at ionic strengths
0.0 and 1.0 M.
From the titration curves, we observe that the ionic-
strength effect is very weak (Fig. 2). These results are not
surprising because ionic strength works by shielding the
FIGURE 1 Schematic representation of the algorithm used.
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interactions between close charged groups, and KTP is a
small molecule without a unique conformation in water.
According to these results, KTP is only mildly positively
charged at physiological pH, reaching the isoelectric point
around pH 8.5. When looking at each site speciﬁcally (Fig.
3), we obtain pKa values for the three relevant titrable sites
(Arg guanidinium is titrating very far away from physiologic
conditions) (Table 1).
It is interesting to compare the N-terminus titration
observed here with the theoretical and experimental ones
in Lopes et al. (74). The pKa of 7.14 computed here with
constant-pH MD is higher than the 6.2 value previously
computed with the LRA method (74). Given that both
methods rely on the same PB/MC and MM/MD approaches
(but combined differently), this discrepancy may be due to
sampling problems in either method or to failure of the linear
response assumption. In particular, we show below (see
‘‘Detailed conformational analysis with PCA’’) that some
conformational classes show sudden changes upon N-termi-
nus titration, which could result in poor distribution overlap
and consequent breakdown of the linear response assump-
tion (see Eberini et al. (32) for details). On the other hand, 6.2
is also the pKa value estimated from the ion exchange
experiment (74) (we note that Fig. 6 a in Lopes et al. (74)
shows the release of positively-charged KTP from an anionic
resin, thus corresponding only to the N-terminus group. This
value seems too low for such an exposed group and actually
makes problematic the interaction with the negatively
charged membrane (74). In any case, this issue could prob-
ably be clariﬁed by further experimental studies.
Conformational mapping with constant-pH MD
As anticipated, our simulations clearly show that KTP does
not have a unique structure in solution. In fact, this dipeptide
showed a remarkable conformational freedom, especially
at low pH values. We started by measuring the molecule
packing at different pH values. This was done by computing
the radius of gyration and the perimeter of the triangle for-
med by the following atoms: N from the N-terminus; O from
Tyr hydroxyl; and C from Arg guanidinium. Both the radius
of gyration and the perimeter are expected to be higher when
the molecule is in an extended conformation and lower
when the molecule is more packed. As seen in Fig. 4, there
FIGURE 2 Titration curves of KTP at different values of ionic strength.
FIGURE 3 Titration curves of KTP titrable sites at 0.1 M.
TABLE 1 pKa values obtained from the titration curves
at I = 0.1 M
Titration site pKa values
N-ter 7.14 6 0.14
Tyr 9.94 6 0.26
Arg .12
C-ter 4.04 6 0.15
pKa values were computed using a third-order polynomial interpolation.
FIGURE 4 Average radius of gyration and average perimeter (triangle
formed between N-terminus, OH (Tyr), and CZ (Arg)) over pH, at 0.1 M
ionic strength.
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is a clear gain of packing with pH increase. Also, the radius
of gyration indicates a slight structural packing at lower pH
values, suggesting that some structure other than the ex-
tended one is being preferred.
From these results, an obvious question arises, namely
what kind of structures are being formed at lower and higher
pH values. A possibility would be that conformational changes
involve an interaction between the two side chains. For
this interaction to take place, the correct alignment between
the Ca and Cb atoms of both residues would be of major
importance. With this in mind, we monitored the dihedral
angle formed between the atoms CbTyr-CaTyr-CaArg-CbArg.
When KTP is in an extended conformation (Fig. 5 a), this
dihedral angle takes values around 180 (trans), and when
the side chains interact with each other (Fig. 5 b), the dihe-
dral angle takes values around 0 (cis).
Our simulations indicate that KTP has a clear prefer-
ence for the cis conformation upon pH increase (Fig. 6). In-
terestingly, at relatively low pH both the N- and C-terminus
are charged and KTP is preferably in the trans conformation,
keeping both termini far apart. Upon pH increase, the
N-terminus looses the charge and KTP prefers the cis con-
formations. These results might seem contradictory at ﬁrst
glance because opposite charges should attract each other.
However, these groups are very exposed to water, and thus
solvation can easily overcome this attraction (see Suppl.
Mat.). In fact, salt bridges between solvent-exposed groups
are usually very weak (87,88), often breaking during
simulations (89,90).
When looking at the histogram surface (Fig. 6), two dis-
tinct populations can be separated from each other. We con-
sidered a conformation to be cis if the dihedral angle is
between70 and 100, and trans otherwise. In this way, we
can quantify the amount of cis KTP at different pH values
(Fig. 7, solid squares). From these results, it is clear that the
trans/cis transition is induced not only by the deprotonation
of the N-terminus (pH 7–8) but also by the deprotonation
of the Tyr-OH (pH 10–11).
The interaction of the side chains was monitored by
following the distance between Tyr-OH and the closest Arg-
NH atoms. From the minima in the histograms (data not
shown), we chose a cutoff of 6 A˚ to deﬁne an interaction,
and used this criterion to determine the number of cis con-
formations with packed side chains (Fig. 7, dashed circles).
FIGURE 5 Two typical conformations of KTP in water. (a) trans
extended conformation; (b) cis packed conformation. The fully protonated
form is represented.
FIGURE 6 Histogram surface of the dihedral angle CB-CA-CA-CB for
KTP at ionic concentration of 0.1 M at different pH values. Ninety-ﬁve
thousand conformations are used for each pH value. Similar data is observed
for 0.0 and 1.0 M ionic strength (data not shown).
FIGURE 7 Percentage of cis conformations over pH (solid squares) and
the percentage of cis conformations with Tyr-Arg interactions (cutoff¼ 6 A˚)
(dashed circles).
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These results show that there is a very relevant number of cis
conformations in which one or both of the side chains prefer
to be solvated rather than interact with each other.
Detailed conformational analysis with PCA
From analysis of the dihedral angle CB-CA-CA-CB we
observed that there is a clear transition from trans to cis
upon pH increase, but the question remains whether all
trans and cis conformers are in extended or packed confor-
mations. In Fig. 7, we showed that there are cis conformers
with noninteracting side chains. To better characterize the
occurring conformations, we did a PCA analysis at different
pH values, whose results are shown in Fig. 8 and Table 2.
We observe that at very low pH values, the C-terminus is
protonated, leading to the preference for a trans conforma-
tion with Tyr-OH interacting with the C-terminus (Tt-c). The
Tswch conformation seems to be a particular case of the
Tt-c peak where the Arg’s side chain is also interacting with
the C-terminus. With the increase of pH, the C-terminus
deprotonates and prefers to become solvated, favoring the
trans conformation with both side chains pointing toward
the solvent (Text). Above pH 8.0, the N-terminus is mainly
deprotonated, which favors the formation of cis conformers.
PCA was able to identify at least four distinct cis peaks, with
the differences lying in the positions of the side chains. By
far the largest peak is the one where both side chains are
pointing toward each other (Ct-a). The conformations where
one or both the side chains are pointing toward the solvent
(Ct-w, Ca-w, and Cext) can be seen as transient. At very high
pH values, the Arg side chain deprotonates and allows
an interaction between Arg-NH and the N-terminus in a trans
conformation (Ta-n).
These PCA results are in good agreement with the cluster-
analysis study of Lopes et al. (74), which reports that the
main conformation clusters obtained for the charged and
neutral N-terminus states were, respectively, the Text and the
Ct-a conformers (using the nomenclature discussed above).
Conformational ﬁt to morphine
Morphine is a pentacyclic compound where almost all
atoms are constrained with little freedom. Part of the struc-
ture of KTP has a strong resemblance to morphine. In fact,
the Tyr residue at the N-terminus of KTP can be mapped
on morphine, fully matching its aromatic ring, as well as part
of its cyclohexane and piperidine rings. For the conforma-
tional ﬁt, we computed the non-mass-weighted root mean-
square deviation (RMSD) between all the conformations
at all pH values (1.1 3 106), and the morphine structure
taken from its complex with an antimorphine antibody (PDB
code 1Q0Y) (91). In this calculation, the atoms N, CA, CB,
CG, CD1, CD2, CE1, CE2, CZ, and OH were considered.
Due to the possible rotation of the phenol ring, two RMSD
calculations were done for each conformation (CD1-CE1
exchanged with CD2-CE2), and the lowest value was chosen.
Since most of the superimposed atoms are geometrically
constrained by the phenol ring, the RMSD value essentially
measures the different orientation of the N and CA atoms
in both molecules. In this way, we obtained an RMSD value
FIGURE 8 Representative conformations from most populated peaks.
The fully protonated forms are represented.
TABLE 2 Population percentage of each conformational peak
at different pH values
pH
Structure 2 3 4 5 6 7 8 9 10 11 12
Tt-c 80.7 71.1 51.4 29.3 25.5 12.8 2.4 — — — —
Tswch — 6.0 — — — — — — — — —
Text 17.1 18.2 47.7 68.5 72.3 84.4 56.6 43.6 42.9 33.1 20.8
Ta-n — — — — — — — — — 2.4 4.5
Ct-a 1.6 4.2 0.8 1.0 0.6 1.9 34.0 42.2 44.7 54.1 66.8
Ca-w — — — — — 0.5 3.9 2.7 8.0 10.1 4.7
Ct-w — — — — — — 1.2 2.2 2.3 — 2.1
Cext — — — — — — 1.6 8.8 1.7 — 1.0
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of 1.083 A˚ for the worse ﬁt and a value of 0.142 A˚ for the
best ﬁt. When a cutoff of 0.2 A˚ was applied, we obtained 156
structures (0.014%) which showed an almost perfect overlap
with morphine (Fig. 9). This shows that KTP can fulﬁll
the structural constraints present in morphine. In this set
of conformers, there are conformations coming from all pH
values, with no clear preference for any particular one (data
not shown). There is also no preference for any cis or trans
conformation (data not shown). Fig. 9 also shows that a very
good ﬁt to morphine turns out to select conformers in which
the Arg side chain never approaches the phenol ring, nor even
the morphine template.
CONCLUSIONS
We have reported a full conformational study of KTP at
different pH values, using a constant-pH MD simulation
method. We showed that KTP does not have a unique
structure in aqueous solution and that the pKa values are not
signiﬁcantly shifted from those of the individual amino
acids. Furthermore, ionic strength does not have a relevant
effect on the titration curves.
The protonation of the N-terminus amine is a preponder-
ant factor in the deﬁnition of both the charge and the
conformation of KTP for receptor interaction. Even though
we predict a pKa of 7.14 for the amine, it is generally
accepted that the pKa can be slightly higher close to the
negatively charged membrane, and that the local pH
should be lower than that of the cytoplasmatic (92). There-
fore, it is likely that, when interacting with its receptor,
KTP is mainly protonated at the N-terminus.
We observed that pH has a strong inﬂuence on KTP’s
conformational preferences. From the packing and the
side-chain position studies, we were able to identify one
of the most important conformational transitions in KTP:
the preference for the cis in detriment of the trans confor-
mations upon pH increase. The key points for this transition
are the deprotonation of both the N-terminus and the Tyr-OH
sites. With PCA, we were able to characterize the different
populations within the cis and trans groups. The two main
populations were the trans extended conformation (Text)
and the cis packed conformation with both side chains in-
teracting with each other (Ct-a). Besides the low-populated
peaks with a transient character (Tswch; Ct-w; Ca-w and Cext),
the method was able to identify two populations that are
only present at extreme pH values (Tt-c and Ta-n).
The structural information about the KTPr is scarce. We
know that its binding pocket has to be different from the
opioid receptors (53,62,73). Nevertheless, there are certain
features in KTP that are common to the opioid analgesics,
and which may direct the interaction with its receptor: 1),
the phenolic ring can interact with the receptor both by
p-stacking and hydrogen bonding; and 2), the N-terminus
amine group, when protonated, can make an ionic bond with
an acidic residue in the receptor. Another important aspect
of the KTP-receptor interaction is orientation. The question
of whether KTP can adopt the correct orientation for receptor
binding is difﬁcult to answer due to the absence of structural
information on the receptor. By ﬁtting the KTP conforma-
tions to the structure of morphine, we tried to exclude the
hypothesis that the KTPr pocket is similar to that of the
m-receptor. Interestingly, we observed exactly the opposite.
The best-ﬁtted KTP conformations revealed several nonob-
vious aspects: 1), there was no preference for any N-terminus
charge or cis/trans conformation in the set; and 2), the
predominance of the extended conformations (both cis and
trans) results in the Arg side chain not invading the vicinities
of the phenol group of the Tyr, allowing this to be presented
to the receptor without any hindering effects. These results
suggest that, despite the fact that KTP does not bind to the
opioid receptors, there is no indication for the KTPr pocket
to be very different from those of the opioid receptors.
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